Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Non-Current Assets (2020 - 2026)

MDxHealth has reported Non-Current Assets over the past 7 years, most recently at $92.9 million for Q1 2026.

  • For Q1 2026, Non-Current Assets changed N/A year-over-year to $92.9 million; the TTM value through Mar 2026 reached $92.9 million, changed N/A, while the annual FY2025 figure was $94.5 million, 4.54% up from the prior year.
  • Non-Current Assets was $92.9 million for Q1 2026 at MDxHealth, down from $94.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $94.5 million in Q4 2025 and bottomed at $90.0 million in Q4 2022.
  • The 5-year median for Non-Current Assets is $91.0 million (2023), against an average of $91.8 million.
  • Year-over-year, Non-Current Assets surged 962.91% in 2022 and then dropped 0.59% in 2024.
  • Over 5 years, Non-Current Assets stood at $90.0 million in 2022, then rose by 1.09% to $91.0 million in 2023, then dropped by 0.59% to $90.4 million in 2024, then increased by 4.54% to $94.5 million in 2025, then decreased by 1.7% to $92.9 million in 2026.
  • The last three reported values for Non-Current Assets were $92.9 million (Q1 2026), $94.5 million (Q4 2025), and $90.4 million (Q4 2024) per Business Quant data.